Paul J. Spiess
- Immunology top 0.1%
- Oncology top 0.2%
- Molecular Biology top 5%
- Genetics top 1%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- Steven A. RosenbergRené LafrenièreNicholas P. RestifoS A RosenbergJames J. MuléSusan SchwarzS. SchwarzChristopher A. Klebanoff
- Topics
- Immunotherapy and Immune Responses (31 papers)CAR-T cell therapy research (17 papers)Immune Cell Function and Interaction (16 papers)
- Cited by
- ImmunologyOncologyBiotechnology
- Partner nations
- United StatesMalaysiaAustralia
In The Last Decade
Paul J. Spiess
40 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Immunology 6.8k
- Oncology 4.8k
- Molecular Biology 2.1k
- Genetics 1.2k
- Radiology, Nuclear Medicine and Imaging 618
Countries citing papers authored by Paul J. Spiess
This map shows the geographic impact of Paul J. Spiess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Spiess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Spiess more than expected).
Fields of papers citing papers by Paul J. Spiess
This network shows the impact of papers produced by Paul J. Spiess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Spiess. The network helps show where Paul J. Spiess may publish in the future.
Co-authorship network of co-authors of Paul J. Spiess
This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Spiess. A scholar is included among the top collaborators of Paul J. Spiess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Spiess. Paul J. Spiess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 120 | |
| 2 | Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T cellsbreakdown → | 812 |
| 3 | 481 | |
| 4 | 68 | |
| 5 | 66 | |
| 6 | 17 | |
| 7 | 141 | |
| 8 | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomabreakdown → | 1480 |
| 9 | 8 | |
| 10 | 86 | |
| 11 | 133 | |
| 12 | Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice. | 76 |
| 13 | 46 | |
| 14 | 140 | |
| 15 | 348 | |
| 16 | 97 | |
| 17 | 106 | |
| 18 | Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.breakdown → | 593 |
| 19 | 8 | |
| 20 | In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens. | 42 |
About Paul J. Spiess
Paul J. Spiess is a scholar working on Immunology, Oncology and Transplantation, having authored 40 papers that have together received 8.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (31 papers), CAR-T cell therapy research (17 papers) and Immune Cell Function and Interaction (16 papers). The work is most often cited by research in Immunology (6.8k citations), Oncology (4.8k citations) and Biotechnology (498 citations). Paul J. Spiess has collaborated with scholars based in United States, Malaysia and Australia. Frequent co-authors include Steven A. Rosenberg, René Lafrenière, Nicholas P. Restifo, S A Rosenberg, James J. Mulé, Susan Schwarz, S. Schwarz, Christopher A. Klebanoff, Paul A. Antony and Douglas C. Palmer. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.